Cargando…
Dopaminergic Positron Emission Tomography Imaging in the Alpha‐Synuclein Preformed Fibril Model Reveals Similarities to Early Parkinson's Disease
BACKGROUND: Positron emission tomography (PET) imaging in early Parkinson's disease (PD) subjects reveals that increased dopamine (DA) turnover and reduced dopamine transporter (DAT) density precede decreases in DA synthesis and storage. The rat α‐synuclein preformed fibril (α‐syn PFF) model pr...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9391270/ https://www.ncbi.nlm.nih.gov/pubmed/35524682 http://dx.doi.org/10.1002/mds.29051 |
_version_ | 1784770834019123200 |
---|---|
author | Sossi, Vesna Patterson, Joseph R. McCormick, Siobhan Kemp, Christopher J. Miller, Kathryn M. Stoll, Anna C. Kuhn, Nathan Kubik, Michael Kochmanski, Joseph Luk, Kelvin C. Sortwell, Caryl E. |
author_facet | Sossi, Vesna Patterson, Joseph R. McCormick, Siobhan Kemp, Christopher J. Miller, Kathryn M. Stoll, Anna C. Kuhn, Nathan Kubik, Michael Kochmanski, Joseph Luk, Kelvin C. Sortwell, Caryl E. |
author_sort | Sossi, Vesna |
collection | PubMed |
description | BACKGROUND: Positron emission tomography (PET) imaging in early Parkinson's disease (PD) subjects reveals that increased dopamine (DA) turnover and reduced dopamine transporter (DAT) density precede decreases in DA synthesis and storage. The rat α‐synuclein preformed fibril (α‐syn PFF) model provides a platform to investigate DA dynamics during multiple stages of α‐syn inclusion‐triggered nigrostriatal degeneration. OBJECTIVES: We investigated multiple aspects of in vivo dopaminergic deficits longitudinally and similarities to human PD using translational PET imaging readouts. METHODS: Longitudinal imaging was performed every 2 months in PFF and control rats for 7 months. [(18)F]‐Fluoro‐3,4‐dihydroxyphenyl‐L‐alanine (FDOPA) imaging was performed to investigate DA synthesis and storage (K(occ)) and DA turnover, estimated by its inverse, the effective distribution volume ratio (EDVR). (11)C‐Methylphenidate (MP) was used to estimate DAT density (BP(ND)). RESULTS: Early DA turnover increases and DAT binding decreases were observed in the ipsilateral striatum of PFF rats, progressing longitudinally. EDVR decreased 26%, 38%, and 47%, and BP(ND) decreased 36%, 50%, and 65% at the 2‐, 4‐, and 6‐month time points, respectively, compared to ipsilateral control striatum. In contrast, deficits in DA synthesis and storage were not observed in the ipsilateral striatum of PFF rats compared to control injections and were relatively preserved up to 6 months (K(occ) decreased 20% at 6 months). CONCLUSIONS: The relative preservation of DA synthesis and storage compared to robust progressive deficits in DAT density and increases in DA turnover in the rat α‐syn PFF model display remarkable face validity to dopaminergic alterations in human PD. © 2022 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society |
format | Online Article Text |
id | pubmed-9391270 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-93912702022-10-14 Dopaminergic Positron Emission Tomography Imaging in the Alpha‐Synuclein Preformed Fibril Model Reveals Similarities to Early Parkinson's Disease Sossi, Vesna Patterson, Joseph R. McCormick, Siobhan Kemp, Christopher J. Miller, Kathryn M. Stoll, Anna C. Kuhn, Nathan Kubik, Michael Kochmanski, Joseph Luk, Kelvin C. Sortwell, Caryl E. Mov Disord Regular Issue Articles BACKGROUND: Positron emission tomography (PET) imaging in early Parkinson's disease (PD) subjects reveals that increased dopamine (DA) turnover and reduced dopamine transporter (DAT) density precede decreases in DA synthesis and storage. The rat α‐synuclein preformed fibril (α‐syn PFF) model provides a platform to investigate DA dynamics during multiple stages of α‐syn inclusion‐triggered nigrostriatal degeneration. OBJECTIVES: We investigated multiple aspects of in vivo dopaminergic deficits longitudinally and similarities to human PD using translational PET imaging readouts. METHODS: Longitudinal imaging was performed every 2 months in PFF and control rats for 7 months. [(18)F]‐Fluoro‐3,4‐dihydroxyphenyl‐L‐alanine (FDOPA) imaging was performed to investigate DA synthesis and storage (K(occ)) and DA turnover, estimated by its inverse, the effective distribution volume ratio (EDVR). (11)C‐Methylphenidate (MP) was used to estimate DAT density (BP(ND)). RESULTS: Early DA turnover increases and DAT binding decreases were observed in the ipsilateral striatum of PFF rats, progressing longitudinally. EDVR decreased 26%, 38%, and 47%, and BP(ND) decreased 36%, 50%, and 65% at the 2‐, 4‐, and 6‐month time points, respectively, compared to ipsilateral control striatum. In contrast, deficits in DA synthesis and storage were not observed in the ipsilateral striatum of PFF rats compared to control injections and were relatively preserved up to 6 months (K(occ) decreased 20% at 6 months). CONCLUSIONS: The relative preservation of DA synthesis and storage compared to robust progressive deficits in DAT density and increases in DA turnover in the rat α‐syn PFF model display remarkable face validity to dopaminergic alterations in human PD. © 2022 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society John Wiley & Sons, Inc. 2022-05-07 2022-08 /pmc/articles/PMC9391270/ /pubmed/35524682 http://dx.doi.org/10.1002/mds.29051 Text en © 2022 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Regular Issue Articles Sossi, Vesna Patterson, Joseph R. McCormick, Siobhan Kemp, Christopher J. Miller, Kathryn M. Stoll, Anna C. Kuhn, Nathan Kubik, Michael Kochmanski, Joseph Luk, Kelvin C. Sortwell, Caryl E. Dopaminergic Positron Emission Tomography Imaging in the Alpha‐Synuclein Preformed Fibril Model Reveals Similarities to Early Parkinson's Disease |
title | Dopaminergic Positron Emission Tomography Imaging in the Alpha‐Synuclein Preformed Fibril Model Reveals Similarities to Early Parkinson's Disease |
title_full | Dopaminergic Positron Emission Tomography Imaging in the Alpha‐Synuclein Preformed Fibril Model Reveals Similarities to Early Parkinson's Disease |
title_fullStr | Dopaminergic Positron Emission Tomography Imaging in the Alpha‐Synuclein Preformed Fibril Model Reveals Similarities to Early Parkinson's Disease |
title_full_unstemmed | Dopaminergic Positron Emission Tomography Imaging in the Alpha‐Synuclein Preformed Fibril Model Reveals Similarities to Early Parkinson's Disease |
title_short | Dopaminergic Positron Emission Tomography Imaging in the Alpha‐Synuclein Preformed Fibril Model Reveals Similarities to Early Parkinson's Disease |
title_sort | dopaminergic positron emission tomography imaging in the alpha‐synuclein preformed fibril model reveals similarities to early parkinson's disease |
topic | Regular Issue Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9391270/ https://www.ncbi.nlm.nih.gov/pubmed/35524682 http://dx.doi.org/10.1002/mds.29051 |
work_keys_str_mv | AT sossivesna dopaminergicpositronemissiontomographyimaginginthealphasynucleinpreformedfibrilmodelrevealssimilaritiestoearlyparkinsonsdisease AT pattersonjosephr dopaminergicpositronemissiontomographyimaginginthealphasynucleinpreformedfibrilmodelrevealssimilaritiestoearlyparkinsonsdisease AT mccormicksiobhan dopaminergicpositronemissiontomographyimaginginthealphasynucleinpreformedfibrilmodelrevealssimilaritiestoearlyparkinsonsdisease AT kempchristopherj dopaminergicpositronemissiontomographyimaginginthealphasynucleinpreformedfibrilmodelrevealssimilaritiestoearlyparkinsonsdisease AT millerkathrynm dopaminergicpositronemissiontomographyimaginginthealphasynucleinpreformedfibrilmodelrevealssimilaritiestoearlyparkinsonsdisease AT stollannac dopaminergicpositronemissiontomographyimaginginthealphasynucleinpreformedfibrilmodelrevealssimilaritiestoearlyparkinsonsdisease AT kuhnnathan dopaminergicpositronemissiontomographyimaginginthealphasynucleinpreformedfibrilmodelrevealssimilaritiestoearlyparkinsonsdisease AT kubikmichael dopaminergicpositronemissiontomographyimaginginthealphasynucleinpreformedfibrilmodelrevealssimilaritiestoearlyparkinsonsdisease AT kochmanskijoseph dopaminergicpositronemissiontomographyimaginginthealphasynucleinpreformedfibrilmodelrevealssimilaritiestoearlyparkinsonsdisease AT lukkelvinc dopaminergicpositronemissiontomographyimaginginthealphasynucleinpreformedfibrilmodelrevealssimilaritiestoearlyparkinsonsdisease AT sortwellcaryle dopaminergicpositronemissiontomographyimaginginthealphasynucleinpreformedfibrilmodelrevealssimilaritiestoearlyparkinsonsdisease |